1. Home
  2. CFLT vs BLCO Comparison

CFLT vs BLCO Comparison

Compare CFLT & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CFLT
  • BLCO
  • Stock Information
  • Founded
  • CFLT 2014
  • BLCO 1853
  • Country
  • CFLT United States
  • BLCO Canada
  • Employees
  • CFLT N/A
  • BLCO N/A
  • Industry
  • CFLT EDP Services
  • BLCO Ophthalmic Goods
  • Sector
  • CFLT Technology
  • BLCO Health Care
  • Exchange
  • CFLT Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • CFLT 5.9B
  • BLCO 4.9B
  • IPO Year
  • CFLT 2021
  • BLCO 2022
  • Fundamental
  • Price
  • CFLT $17.79
  • BLCO $14.93
  • Analyst Decision
  • CFLT Buy
  • BLCO Hold
  • Analyst Count
  • CFLT 30
  • BLCO 11
  • Target Price
  • CFLT $29.13
  • BLCO $15.80
  • AVG Volume (30 Days)
  • CFLT 11.9M
  • BLCO 943.3K
  • Earning Date
  • CFLT 07-30-2025
  • BLCO 07-30-2025
  • Dividend Yield
  • CFLT N/A
  • BLCO N/A
  • EPS Growth
  • CFLT N/A
  • BLCO N/A
  • EPS
  • CFLT N/A
  • BLCO N/A
  • Revenue
  • CFLT $1,064,824,000.00
  • BLCO $4,891,000,000.00
  • Revenue This Year
  • CFLT $21.52
  • BLCO $7.10
  • Revenue Next Year
  • CFLT $18.36
  • BLCO $5.50
  • P/E Ratio
  • CFLT N/A
  • BLCO N/A
  • Revenue Growth
  • CFLT 23.02
  • BLCO 8.81
  • 52 Week Low
  • CFLT $15.64
  • BLCO $10.45
  • 52 Week High
  • CFLT $37.90
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • CFLT 37.29
  • BLCO 64.22
  • Support Level
  • CFLT $16.76
  • BLCO $14.24
  • Resistance Level
  • CFLT $18.50
  • BLCO $14.80
  • Average True Range (ATR)
  • CFLT 0.79
  • BLCO 0.44
  • MACD
  • CFLT 0.17
  • BLCO 0.05
  • Stochastic Oscillator
  • CFLT 75.17
  • BLCO 92.72

About CFLT Confluent Inc.

Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: